Hepatitis C virus infection in the Middle East and North Africa "mENA" region: Injecting drug users (IDUs) is an under-investigated population

Infection

Volumn 40, Issue 1, 2012, Pages 1-10

  Ramia, S ^a   Melhem, N M ^a   Kreidieh, K ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Hepatitis C virus; Injecting drug users; Middle East; North Africa

Indexed keywords

CULTURAL FACTOR; DEVELOPING COUNTRY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MEDICAL LITERATURE; MEDICAL RESEARCH; MIDDLE EAST; NORTH AFRICA; PREVALENCE; RELIGION; RESEARCH SUBJECT; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

AFRICA, NORTHERN; DRUG USERS; FEMALE; GUIDELINES AS TOPIC; HARM REDUCTION; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE EAST; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84857785587     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0236-z     Document Type: Review

References (157)

1. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton 1989 Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 359 362 2523562 1:CAS:528:DyaL1MXit1Khtrk%3D 10.1126/science.2523562 (Pubitemid 19117877)
2. World Health Organization (WHO) 1999 Hepatitis C-global prevalence (update) Wkly Epidemiol Rec 74 425 427
3. P Farci RH Purcell 2000 Clinical significance of hepatitis C virus genotypes and quasispecies Semin Liver Dis 20 103 126 10895435 1:CAS:528:DC%2BD3cXltV2rs7o%3D (Pubitemid 30421412)
4. GM Lauer BD Walker 2001 Hepatitis C virus infection N Engl J Med 345 41 52 11439948 1:STN:280:DC%2BD3MzosFGrug%3D%3D 10.1056/NEJM200107053450107 (Pubitemid 32634271)
5. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, editor. Blood safety in the new millennium. Bethesda, MD: American Association of Blood Banks (AABB); 2001. p. 33-54.
6. D Prati 2002 Transmission of viral hepatitis by blood and blood derivatives: current risks, past heritage Dig Liver Dis 34 812 817 12546518 1:STN:280:DC%2BD3s%2FjvVeitQ%3D%3D 10.1016/S1590-8658(02)80076-7 (Pubitemid 36097522)
7. S Laperche 2005 Blood safety and nucleic acid testing in Europe Euro Surveill 10 3 4 15735316 1:STN:280:DC%2BD2MvmsVKjtQ%3D%3D
8. J Pillonel S Laperche Etablissement Français du sang 2005 Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) Euro Surveill 10 5 8 15735313 1:STN:280:DC%2BD2MvmsVKjtg%3D%3D
9. T Sy MM Jamal 2006 Epidemiology of hepatitis C virus (HCV) infection Int J Med Sci 3 41 46 16614741 10.7150/ijms.3.41
10. JI Esteban S Sauleda J Quer 2008 The changing epidemiology of hepatitis C virus infection in Europe J Hepatol 48 148 162 18022726 10.1016/j.jhep.2007.07. 033 (Pubitemid 350191999)
11. Health Protection Agency. Shooting up. Infections among injecting drug users in the United Kingdom 2005. An update: October 2006. Health Protection Agency, Centre for Infections; Health Protection Scotland; National Public Health Service for Wales; Communicable Disease Surveillance Centre Northern Ireland; Centre for Research on Drugs & Health Behaviour, London School of Hygiene & Tropical Medicine. 2006. http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb-C/1194947378477.
12. S Touzet L Kraemer C Colin P Pradat D Lanoir F Bailly RC Coppola S Sauleda MR Thursz H Tillmann A Alberti JH Braconier JI Esteban SJ Hadziyannis MP Manns G Saracco HC Thomas C Trépo 2000 Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research) Eur J Gastroenterol Hepatol 12 667 678 10912488 1:STN:280: DC%2BD3M%2FivFartg%3D%3D 10.1097/00042737-200012060-00017 (Pubitemid 30433545)
13. C Mathei Z Shkedy B Denis C Kabali M Aerts G Molenberghs P Van Damme F Buntinx 2006 Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users J Viral Hepat 13 560 570 16901287 1:STN:280: DC%2BD28vnvVamtQ%3D%3D 10.1111/j.1365-2893.2006.00725.x (Pubitemid 44100408)
14. A Judd S Hutchinson S Wadd M Hickman A Taylor S Jones JV Parry S Cameron T Rhodes S Ahmed S Bird R Fox A Renton GV Stimson D Goldberg 2005 Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis J Viral Hepat 12 655 662 16255768 1:STN:280:DC%2BD2MrnvFyntg%3D%3D 10.1111/j.1365-2893.2005.00643.x (Pubitemid 41532498)
15. W Sievert I Altraif HA Razavi A Abdo EA Ahmed A Alomair D Amarapurkar CH Chen X Dou H El Khayat M Elshazly G Esmat R Guan KH Han K Koike A Largen G McCaughan S Mogawer A Monis A Nawaz T Piratvisuth FM Sanai AI Sharara S Sibbel A Sood DJ Suh C Wallace K Young F Negro 2011 A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt Liver Int 31 61 80 21651703 10.1111/j.1478-3231.2011.02540.x
16. AA Qadi H Tamim G Ameen A Bu-Ali S Al-Arrayed NA Fawaz WY Almawi 2004 Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods Am J Infect Control 32 493 495 15573057 10.1016/j.ajic.2003.12.009 (Pubitemid 39574475)
17. M Altindis S Yilmaz T Dikengil H Acemoglu S Hosoglu 2006 Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus World J Gastroenterol 12 6792 6796 17106927 (Pubitemid 44811400)
18. X Dray R Dray-Spira JA Bronstein D Mattera 2005 Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti Med Trop (Mars) 65 39 42 1:STN:280:DC%2BD2M3mt1ehsQ%3D%3D
19. AM Ismail HN Ziada HA Sheashaa AB Shehab El-Din 2009 Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope Eur J Intern Med 20 490 493 19712851 10.1016/j.ejim.2009.03.005
20. AH El-Gilany S El-Fedawy 2006 Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt East Mediterr Health J 12 742 748 17333818 (Pubitemid 46358268)
21. A Youssef Y Yano T Utsumi EM abd El-alah Ael-E abd El-Hameed Ael-H Serwah Y Hayashi 2009 Molecular epidemiological study of hepatitis viruses in Ismailia, Egypt Intervirology 52 123 131 19468235 1:CAS:528:DC%2BD1MXnslyru7c%3D 10.1159/000219385
22. S Shalaby IA Kabbash G El Saleet N Mansour A Omar A El Nawawy 2010 Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt East Mediterr Health J 16 10 17 20214151 1:STN:280:DC%2BC3c7ntVelug%3D%3D
23. SK Stoszek M Abdel-Hamid S Narooz M El Daly DA Saleh N Mikhail E Kassem Y Hawash S El Kafrawy A Said M El Batanony FM Shebl M Sayed S Sharaf AD Fix GT Strickland 2006 Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women Trans R Soc Trop Med Hyg 100 102 107 16289168 10.1016/j.trstmh.2005.05.021 (Pubitemid 43024765)
24. SM Alavian F Fallahian 2009 Epidemiology of hepatitis C in Iran and the world Shiraz E Med J 10 162 172
25. F Farshadpour M Makvandi AR Samarbafzadeh MA Jalalifar 2010 Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran Indian J Med Microbiol 28 54 56 20061766 1:STN:280:DC%2BC3c%2FhsFKmuw%3D%3D 10.4103/0255-0857.58731
26. SA Kafi-abad H Rezvan H Abolghasemi A Talebian 2009 Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 Transfusion. 49 2214 2220 19527477 10.1111/j.1537-2995.2009.02245.x
27. H Khedmat F Fallahian H Abolghasemi SM Alavian B Hajibeigi SM Miri AM Jafari 2007 Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors Pak J Biol Sci 10 4461 4466 19093512 10.3923/pjbs.2007.4461.4466 (Pubitemid 350305614)
28. AA Ghavanini MR Sabri 2000 Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran East Mediterr Health J 6 1114 1116 12197336 1:STN:280:DC%2BD38vjvFOrtg%3D%3D
29. MA Assarehzadegan G Shakerinejad R Noroozkohnejad A Amini SA Rahim Rezaee 2009 Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran Saudi J Kidney Dis Transpl 20 681 684 19587521
30. A Makhlough M Jamshidi MR Mahdavi 2008 Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran Singapore Med J 49 921 923 19037560 1:STN:280: DC%2BD1cjmvFGnsg%3D%3D
31. O Taziki F Espahbodi 2008 Prevalence of hepatitis C virus infection in hemodialysis patients Saudi J Kidney Dis Transpl 19 475 478 18445917 1:STN:280:DC%2BD1c3otlKmsQ%3D%3D
32. ZM Amiri AJ Shakib M Toorchi 2005 Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran East Mediterr Health J 11 372 376 16602456 1:STN:280:DC%2BD287ps1Crtw%3D%3D
33. SM Alavian B Einollahi B Hajarizadeh S Bakhtiari M Nafar S Ahrabi 2003 Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients Nephrology (Carlton) 8 256 260 10.1046/j.1440-1797.2003. 00166.x (Pubitemid 37430951)
34. MM Ansar A Kooloobandi 2002 Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht J Viral Hepat 9 390 392 12225335 1:STN:280:DC%2BD38vms1GrtA%3D%3D 10.1046/j.1365-2893.2002.00368.x
35. S Mirmomen SM Alavian B Hajarizadeh J Kafaee B Yektaparast MJ Zahedi V Zand AA Azami HM Hosseini AR Faridi K Davari B Hajibeigi 2006 Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study Arch Iran Med 9 319 323 17061602 (Pubitemid 44803571)
36. M Karimi AA Ghavanini 2001 Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran J Paediatr Child Health 37 564 566 11903836 1:STN:280:DC%2BD387mvFyhtQ%3D%3D 10.1046/j.1440-1754.2001.00709.x (Pubitemid 34042952)
37. B Sharifi-Mood P Eshghi E Sanei-Moghaddam M Hashemi 2007 Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran Saudi Med J 28 1516 1519 17914511 (Pubitemid 350065136)
38. F Mansour-Ghanaei MS Fallah A Shafaghi M Yousefi-Mashhoor N Ramezani F Farzaneh R Nassiri 2002 Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran) Med Sci Monit 8 CR797 CR800 12503038
39. M Karimi AA Ghavanini 2001 Seroprevalence of HBsAg, anti-HCV, and anti-HIV among haemophiliac patients in Shiraz, Iran Haematologia (Budap) 31 251 255 1:STN:280:DC%2BD387itFelug%3D%3D 10.1163/15685590152763809 (Pubitemid 34134209)
40. Z Mohtasham Amiri M Rezvani R Jafari Shakib A Jafari Shakib 2007 Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province East Mediterr Health J 13 250 256 17684845 1:STN:280:DC%2BD2svmslCjuw%3D%3D (Pubitemid 47045989)
41. OS Khattab 2008 Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center Saudi J Kidney Dis Transpl 19 110 115 18087139
42. WA Al-Kubaisy KT Al-Naib M Habib 2006 Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia East Mediterr Health J 12 204 210 17037239 1:STN:280:DC%2BD28ngsVyktA%3D%3D (Pubitemid 44339886)
43. Y Maor D Bashari G Kenet S Lalezari A Lubetsky J Luboshitz JM Schapiro B Avidan S Bar-Meir U Martinowitz 2006 Hepatitis C at the Israeli national hemophilia center Haemophilia 12 68 74 16409178 1:STN:280: DC%2BD28%2Fit1ymtw%3D%3D 10.1111/j.1365-2516.2006.01178.x
44. H Shirin Y Davidovitz Y Avni P Petchenko Z Krepel R Bruck D Meytes 2002 Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders Isr Med Assoc J 4 24 27 11802304 (Pubitemid 34193062)
45. S Sermoneta-Gertel M Donchin R Adler M Baras T Perlstein N Manny D Shouval E Galun 2001 Hepatitis C virus infection in employees of a large university hospital in Israel Infect Control Hosp Epidemiol 22 754 761 11876453 1:STN:280:DC%2BD387ksVCrsg%3D%3D 10.1086/501858 (Pubitemid 34157716)
46. T Weinstein R Tur-Kaspa A Chagnac A Korzets Y Ori D Zevin M Herman U Gafter 2001 Hepatitis C infection in dialysis patients in Israel Isr Med Assoc J 3 174 177 11303373 1:STN:280:DC%2BD3M3jslemtw%3D%3D (Pubitemid 32432964)
47. S Bdour 2002 Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping J Med Microbiol 51 700 704 12171303 (Pubitemid 34804296)
48. M Al-Jamal A Al-Qudah KF Al-Shishi A Al-Sarayreh L Al-Quraan 2009 Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan Saudi J Kidney Dis Transpl 20 488 492 19414962
49. A Quadan 2002 Prevalence of anti hepatitis C virus among the hospital populations in Jordan New Microbiol 25 269 273 12173766
50. M Al-Sheyyab A Batieha M El-Khateeb 2001 The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients J Trop Pediatr 47 239 242 11523766 1:STN:280:DC%2BD3MvotVentg%3D%3D 10.1093/tropej/47.4.239 (Pubitemid 32771423)
51. R Ameen N Sanad S Al-Shemmari I Siddique RI Chowdhury S Al-Hamdan A Al-Bashir 2005 Prevalence of viral markers among first-time Arab blood donors in Kuwait Transfusion 45 1973 1980 16371052 10.1111/j.1537-2995.2005.00635.x (Pubitemid 43971426)
52. N Irani-Hakime U Musharrafieh H Samaha WY Almawi 2006 Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003 Am J Infect Control 34 241 243 16679184 10.1016/j.ajic.2005. 06.009
53. N Irani-Hakime H Tamim H Samaha WY Almawi 2001 Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000 Clin Lab Haematol 23 317 323 11703415 1:STN:280:DC%2BD3MnmsFWmtg%3D%3D 10.1046/j.1365-2257.2001.00409.x (Pubitemid 32995162)
54. H Tamim N Irani-Hakime JP Aoun S Khoury H Samaha WY Almawi 2001 Seroprevalence of hepatitis C virus (HCV) infection among blood donors: a hospital-based study Transfus Apher Sci 24 29 35 11515608 1:STN:280: DC%2BD3MvmvF2rsQ%3D%3D 10.1016/S0955-3886(00)00124-7 (Pubitemid 33062324)
55. S Ramia S Koussa A Taher S Haraki S Klayme D Sarkis R Naman 2002 Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics Ann Trop Med Parasitol 96 197 202 12080981 1:STN:280: DC%2BD38zjvVWgsA%3D%3D 10.1179/000349802125000439 (Pubitemid 34298955)
56. S Ramia S Klayme R Naman 2003 Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients Ann Trop Med Parasitol 97 187 192 12803874 1:STN:280:DC%2BD3s3ns12qsQ%3D%3D 10.1179/000349803235001363 (Pubitemid 36543240)
57. Z Mahfoud K Kassak K Kreidieh S Shamra S Ramia 2010 Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon J Infect Dev Ctries 4 144 149 20351454
58. N Irani-Hakime J Aoun S Khoury HR Samaha H Tamim WY Almawi 2001 Seroprevalence of hepatitis C infection among health care personnel in Beirut, Lebanon Am J Infect Control 29 20 23 11172314 1:STN:280:DC%2BD3MzgtV2ksQ%3D%3D 10.1067/mic.2001.110777 (Pubitemid 32165069)
59. R Baddoura C Haddad M Germanos 2002 Hepatitis B and C seroprevalence in the Lebanese population East Mediterr Health J 8 150 156 15330570 1:STN:280:DC%2BD2cvisFakug%3D%3D (Pubitemid 39162501)
60. H Kutrani A El-Gatit A Shekhteryea Y El-Gitait O Sudani S Akoub 2007 Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab Jamahiriya East Mediterr Health J 13 85 97 17546910 (Pubitemid 47243845)
61. S Sekkat N Kamal B Benali H Fellah K Amazian A Bourquia A El Kholti A Benslimane 2008 Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco Nephrol Ther 4 105 110 18272446 (Pubitemid 351508502)
62. K Boulaajaj Y Elomari B Elmaliki B Madkouri D Zaid N Benchemsi 2005 Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca Nephrol Ther 1 274 284 16895696 (Pubitemid 41719286)
63. P Cacoub V Ohayon S Sekkat B Dumont A Sbai F Lunel A Benslimane P Godeau MI Archane 2000 Epidemiologic and virologic study of hepatitis C virus infections in Morocco Gastroenterol Clin Biol 24 169 173 12687957 1:STN:280:DC%2BD3s7ntVCjtA%3D%3D
64. A Benouda Z Boujdiya S Ahid R Abouqal M Adnaoui 2009 Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction Pathol Biol (Paris) 57 368 372 1:STN:280:DC%2BD1MvltVOkuw%3D%3D 10.1016/j.patbio.2008.07.006
65. A Rikabi A Bener A Al-Marri S Al-Thani 2009 Hepatitis B and C viral infections in chronic liver disease: a population based study in Qatar East Mediterr Health J 15 778 784 20187528 1:STN:280:DC%2BC3c7ktlOksQ%3D%3D
66. MM El-Hazmi 2004 Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia Saudi Med J 25 26 33 14758374 (Pubitemid 38262504)
67. MA Daw MA Elkaber AM Drah MM Werfalli AA Mihat IM Siala 2002 Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk Saudi Med J 23 1356 1360 12506296 (Pubitemid 36113491)
68. OA Shobokshi FE Serebour AZ Al-Drees AH Mitwalli A Qahtani LI Skakni 2003 Hepatitis C virus seroprevalence rate among Saudis Saudi Med J 24 S81 S86 12897907
69. A Karkar 2007 Hepatitis C in dialysis units: the Saudi experience Hemodial Int 11 354 367 17576302 10.1111/j.1542-4758.2007.00192.x (Pubitemid 46958591)
70. MS Harakati OA Abualkhair BA Al-Knawy 2000 Hepatitis C virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma Saudi Med J 21 755 758 11423889 1:STN:280:DC%2BD3MzmtlSqug%3D%3D
71. YA Nur J Groen AM Elmi A Ott AD Osterhaus 2000 Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia Epidemiol Infect 124 137 141 10722141 1:STN:280: DC%2BD3c7osFaitA%3D%3D 10.1017/S0950268899003441 (Pubitemid 30103420)
72. MA Abou YM Eltahir AS Ali 2009 Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan Virol J 6 146 19775459 10.1186/1743-422X-6-146 1:CAS:528:DC%2BD1MXht1alt77M
73. HH El-Amin EM Osman MO Mekki MB Abdelraheem MO Ismail ME Yousif AM Abass HS El-haj HK Ammar 2007 Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report Saudi J Kidney Dis Transpl 18 101 106 17237901 1:STN:280:DC%2BD2s%2FjvFWjsw%3D%3D
74. RM Elsheikh AA Daak MA Elsheikh MS Karsany I Adam 2007 Hepatitis B virus and hepatitis C virus in pregnant Sudanese women Virol J 4 104 17958904 10.1186/1743-422X-4-104 1:CAS:528:DC%2BD2sXhtl2rs73E (Pubitemid 350231411)
75. BM Othman FS Monem 2002 Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria Saudi Med J 23 393 395 11953762 (Pubitemid 34460853)
76. G Moukeh R Yacoub F Fahdi S Rastam S Albitar 2009 Epidemiology of hemodialysis patients in Aleppo city Saudi J Kidney Dis Transpl 20 140 146 19112237
77. B Othman F Monem 2001 Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria Infection 29 262 265 11688903 1:STN:280:DC%2BD3MnjsFCqsg%3D%3D 10.1007/s15010-001-9156-7 (Pubitemid 32929631)
78. BM Othman FS Monem 2001 Prevalence of hepatitis C virus antibodies among health care workers in Damascus, Syria Saudi Med J 22 603 605 11479642 1:STN:280:DC%2BD38%2FislOisg%3D%3D (Pubitemid 33694441)
79. SA Hatira S Yacoub-Jemni B Houissa H Kaabi M Zaeir M Kortas L Ghachem 2000 Hepatitis C virus antibodies in 34130 blood donors in Tunisian Sahel Tunis Med 78 101 105 10894044 1:STN:280:DC%2BD3czpvFejsg%3D%3D
80. F Hmaied M Ben Mamou K Saune-Sandres L Rostaing A Slim Z Arrouji S Ben Redjeb J Izopet 2006 Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission J Med Virol 78 185 191 16372289 1:CAS:528:DC%2BD28XhtVylsL8%3D 10.1002/jmv.20526 (Pubitemid 43132562)
81. S Ben Othman N Bouzgarrou A Achour T Bourlet B Pozzetto A Trabelsi 2004 High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia Pathol Biol (Paris) 52 323 327 1:STN:280:DC%2BD2cvhslKrug%3D%3D 10.1016/j.patbio.2003.07.001 (Pubitemid 38916891)
82. S Mejri AB Salah H Triki NB Alaya A Djebbi K Dellagi 2005 Contrasting patterns of hepatitis C virus infection in two regions from Tunisia J Med Virol 76 185 193 15834884 1:CAS:528:DC%2BD2MXksFyhtbY%3D 10.1002/jmv.20342 (Pubitemid 40594002)
83. G Bozdayi S Rota H Verdi U Derici S Sindel M Bali T Başay 2002 The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution Mikrobiyol Bul 36 291 300 12838663 1:CAS:528:DC%2BD3sXltlyntr0%3D (Pubitemid 36701972)
84. F Yakaryilmaz OA Gurbuz S Guliter A Mert Y Songur T Karakan H Keles 2006 Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients Ren Fail 28 729 735 17162434 10.1080/08860220600925602 (Pubitemid 44950009)
85. AI Olut F Ozsakarya M Dilek 2005 Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey J Int Med Res 33 641 646 16372581 1:STN:280: DC%2BD2MnosVemuw%3D%3D (Pubitemid 43009590)
86. D Sit AK Kadiroglu H Kayabasi ME Yilmaz V Goral 2007 Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a University hospital in Turkey Intervirology 50 133 137 17191015 1:CAS:528:DC%2BD2sXhsV2itL0%3D 10.1159/000098239
87. N Savas S Ocal T Colak H Karakayali U Yilmaz M Haberal 2007 Clinical course of hepatitis C virus infection in renal transplant recipients Transplant Proc 39 984 986 17524869 1:STN:280:DC%2BD2szhtlSjsQ%3D%3D 10.1016/j. transproceed.2007.02.047 (Pubitemid 46764843)
88. S Altinbas M Erdogan N Danişman 2010 The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara Arch Gynecol Obstet 281 371 19521710 10.1007/s00404-009-1145-6
89. I Maral F Dogruman-Al C Bakar MN Ilhan M Yalinay-Cirak MA Bumin 2009 Hepatitis B virus and hepatitis C virus seroprevalence in the elderly living in nursing homes J Investig Med 57 717 719 19436221
90. B Yildirim S Barut Y Bulut G Yenişehirli M Ozdemir I Cetin I Etikan A Akbaş O Atiş H Ozyurt S Sahin 2009 Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: a population-based study Turk J Gastroenterol 20 27 30 19330732
91. S Erden S Büyüköztürk S Calangu G Yilmaz S Palanduz S Badur 2003 A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey Med Princ Pract 12 184 188 12766338 1:STN:280: DC%2BD3s3ksVSqsw%3D%3D 10.1159/000070757 (Pubitemid 36667651)
92. ZC Ozer E Efe S Oncel H Taskinsoy M Ulker 2009 Hepatitis B-hepatitis C seroprevalences and blunt-penetrating object injuries in housekeepers in Turkey: a survey study J Clin Nurs 18 294 300 19120756 10.1111/j.1365-2702.2008.02330.x
93. MF Ozsoy O Oncul S Cavuslu A Erdemoglu G Emekdas A Pahsa 2003 Seroprevalences of hepatitis B and C among health care workers in Turkey J Viral Hepat 10 150 156 12614472 1:STN:280:DC%2BD3s7gtlansg%3D%3D 10.1046/j.1365-2893. 2003.00404.x (Pubitemid 36359853)
94. A Isikdogan O Ayyildiz M Dursun N Tiftik S Batun E Muftuoglu 2003 Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients Leuk Lymphoma 44 1745 1747 14692528 10.1080/1042819031000116724 (Pubitemid 37229050)
95. N Yenice F Güllük N Arican S Türkmen 2003 HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases Turk J Gastroenterol 14 173 176 14655060 (Pubitemid 37493789)
96. F Candan H Alagözlü O Poyraz H Sümer 2002 Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey Occup Med (Lond) 52 31 34 1:STN:280:DC%2BD387nsVWmtA%3D%3D 10.1093/occmed/52.1.31 (Pubitemid 34213627)
97. M Al-Moslih 2010 Occult hepatitis C virus infection among chronic liver disease patients in the United Arab Emirates Int J Infect Dis 14 225 226 10.1016/j.ijid.2010.02.1990
98. MA Bajubair AA Elrub G Bather 2008 Hepatic viral infections in Yemen between 2000-2005 Saudi Med J 29 871 874 18521468
99. TA Sallam CY Tong LE Cuevas YA Raja'a AM Othman KR Al-Kharsa 2003 Prevalence of blood-borne viral hepatitis in different communities in Yemen Epidemiol Infect 131 771 775 12948378 1:STN:280:DC%2BD3svgvFSlsA%3D%3D 10.1017/S0950268803008653 (Pubitemid 37062900)
100. NA Haidar 2002 Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic Saudi Med J 23 1090 1094 12370719 (Pubitemid 35331310)
101. R Shidrawi M Ali Al-Huraibi M Ahmad Al-Haimi R Dayton IM Murray-Lyon 2004 Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers J Med Virol 73 562 565 15221900 10.1002/jmv.20126 (Pubitemid 38857206)
102. MI Al-Moslih MA Al-Huraibi 2001 Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen East Mediterr Health J 7 771 778 15332778 1:STN:280:DC%2BD2cvislGjtQ%3D%3D
103. A Elkady Y Tanaka F Kurbanov F Sugauchi M Sugiyama A Khan D Sayed G Moustafa AR Abdel-Hameed M Mizokami 2009 Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication J Med Virol 81 1015 1023 19382263 1:CAS:528:DC%2BD1MXmtVWisL0%3D 10.1002/jmv.21492
104. M Abdel-Hamid M El-Daly V Molnegren S El-Kafrawy S Abdel-Latif G Esmat GT Strickland C Loffredo J Albert A Widell 2007 Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma J Gen Virol 88 1526 1531 17412982 1:CAS:528:DC%2BD2sXlsV2lsr0%3D 10.1099/vir.0.82626-0 (Pubitemid 46723235)
105. EM Elsawy MA Sobh FA El-Chenawi IM Hassan AB Shehab El-Din MA Ghoneim 2005 Serotyping of hepatitis C virus in hemodialysis patients: comparison with a standardized genotyping assay Diagn Microbiol Infect Dis 51 91 94 15698713 1:CAS:528:DC%2BD2MXhtV2ntLo%3D 10.1016/j.diagmicrobio.2004.09.010 (Pubitemid 40215417)
106. SC Ray RR Arthur A Carella J Bukh DL Thomas 2000 Genetic epidemiology of hepatitis C virus throughout Egypt J Infect Dis 182 698 707 10950762 1:CAS:528:DC%2BD3cXmvVCjt74%3D 10.1086/315786
107. SM Hosseini-Moghaddam H Keyvani H Kasiri SM Kazemeyni A Basiri N Aghel SM Alavian 2006 Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran-a multicenter study J Med Virol 78 569 573 16555284 1:CAS:528:DC%2BD28XksFWgtbg%3D 10.1002/jmv.20577
108. MH Somi H Keivani MR Ardalan S Farhang AA Pouri 2008 Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran Saudi J Kidney Dis Transpl 19 461 465 18445914
109. MR Zali M Mayumi M Raoufi A Nowroozi 2000 Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study East Mediterr Health J 6 372 377 11556026 1:STN:280:DC%2BD3MrgslGkug%3D%3D
110. NJ Makhoul MB Choueiri MM Kattar AM Soweid W Shamseddeen HC Estephan J Khalife A Haddad A Abi Rached PA Zalloua 2008 Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon J Clin Virol 41 166 167 18054277 1:STN:280:DC%2BD1c%2FovV2hug%3D%3D 10.1016/j.jcv.2007.10.012 (Pubitemid 351187891)
111. AI Sharara S Ramia F Ramlawi JE Fares S Klayme R Naman 2007 Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries Epidemiol Infect 135 427 432 16848924 1:CAS:528:DC%2BD2sXksV2qurY%3D 10.1017/S0950268806006911 (Pubitemid 46443428)
112. N Irani-Hakime H Samaha W Almawi E Nasr J Mokhbat M Abou Jaoude J Daccache E Rahal 2003 Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients: a hospital-based study J Med Liban 51 121 126 15707071 (Pubitemid 39390027)
113. WA Alashek M Altagdi 2008 Risk factors and genotypes of hepatitis C virus infection in Libyan patients Libyan J Med 3 162 165 21499468 10.4176/080425
114. BM Ayesh SS Zourob SY Abu-Jadallah Y Shemer-Avni 2009 Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study Virol J 6 105 19607718 10.1186/1743-422X-6-105 1:CAS:528:DC%2BD1MXptFSltbs%3D
115. OA Shobokshi FE Serebour LI Skakni 2003 Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia Saudi Med J 24 S87 S91 12897908
116. N Antaki M Haddad K Kebbewar J Abdelwahab O Hamed R Aaraj N Alhaj S Haffar M Assil M Ftayeh F Assaad D Doghman T Ali M Nasserelddine A Ali F Antaki Syrian Working Group for the Study of Viral Hepatitis 2009 The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province Epidemiol Infect 137 79 84 18346288 1:STN:280:DC%2BD1M%2Fos1Gkuw%3D%3D 10.1017/S095026880800054X
117. A Djebbi H Triki O Bahri I Cheikh A Sadraoui A Ben Ammar K Dellagi 2003 Genotypes of hepatitis C virus circulating in Tunisia Epidemiol Infect 130 501 505 12825736 1:CAS:528:DC%2BD3sXltFKltL0%3D 10.1017/S095026880300846X (Pubitemid 36722790)
118. I Altuglu I Soyler T Ozacar S Erensoy 2008 Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey Int J Infect Dis 12 239 244 17942359 1:CAS:528:DC%2BD1cXntF2gsLY%3D 10.1016/j.ijid.2007.07.003 (Pubitemid 351539094)
119. VL Demetriou DA van de Vijver J Hezka LG Kostrikis Cyprus IVDU Network LG Kostrikis 2010 Cyprus IVDU Network, Kostrikis LG. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus J Med Virol 82 263 270 20029809 1:CAS:528:DC%2BC3cXkt1ahurc%3D 10.1002/jmv.21690
120. A Paez Jimenez MK Mohamed NS Eldin HA Seif S Aidi Y Sultan N Elsaid C Rekacewicz M El-Hoseiny M El-Daly M Abdel-Hamid A Fontanet 2009 Injection drug use is a risk factor for HCV infection in urban Egypt PLoS One 4 e7193 19784363 10.1371/journal.pone.0007193 1:CAS:528:DC%2BD1MXhsVSjurzM
121. A Rahimi-Movaghar EM Razaghi E Sahimi-Izadian M Amin-Esmaeili 2010 HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran Int J Infect Dis 14 e28 e33 19464218 10.1016/j.ijid.2009. 03.002
122. M Zakizad F Salmeh T Yaghoobi M Yaghoubian MB Nesami Z Esmaeeli N Vaezzadeh S Shahmohammadi S Modanloo AA Sadeghian SJ Abdolmanafi RA Mohammadpour H Siamian A Khosravi 2009 Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran Pak J Biol Sci 12 1012 1018 19947179 1:STN:280:DC%2BD1MjptFCrtg%3D%3D 10.3923/pjbs.2009.1012.1018
123. P Kheirandish S SeyedAlinaghi M Jahani H Shirzad M Seyed Ahmadian A Majidi A Sharifi M Hosseini M Mohraz W McFarland 2009 Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran J Urban Health 86 902 908 19844670 10.1007/s11524-009-9393-0
124. R Imani A Karimi R Rouzbahani A Rouzbahani 2008 Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran East Mediterr Health J 14 1136 1141 19161086 1:STN:280:DC%2BD1M%2FovVynsw%3D%3D
125. S Zamani S Ichikawa B Nassirimanesh M Vazirian K Ichikawa MM Gouya P Afshar M Ono-Kihara SM Ravari M Kihara 2007 Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran Int J Drug Policy 18 359 363 17854723 10.1016/j.drugpo.2007.02.007 (Pubitemid 47374506)
126. AH Mohammad Alizadeh SM Alavian K Jafari N Yazdi 2005 Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran World J Gastroenterol 11 4085 4089 15996035 (Pubitemid 41235607)
127. R Loebstein R Mahagna Y Maor D Kurnik E Elbaz H Halkin D Olchovsky D Ezra S Almog 2008 Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors Isr Med Assoc J 10 775 778 19070285
128. Z Mahfoud K Kassak K Kreidieh S Shamra S Ramia 2010 Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon Virol J 7 96 20465784 10.1186/1743-422X-7-96
129. AJ Alzahrani DM Dela Cruz OE Obeid HA Bukhari AA Al-Qahtani MN Al-Ahdal 2009 Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia J Med Virol 81 1343 1347 19551834 1:CAS:528:DC%2BD1MXptVKrtrg%3D 10.1002/jmv.21487
130. AO Osoba 2002 Hepatitis C virus genotypes in Saudi Arabia Saudi Med J 23 7 12 11938356 (Pubitemid 34187712)
131. MJ Alter D Kruszon-Moran OV Nainan GM McQuillan F Gao LA Moyer RA Kaslow HA Margolis 1999 The prevalence of hepatitis C virus infection in the United
132. T Tanaka N Kato MJ Cho K Shimotohno 1995 A novel sequence found at the 3′ terminus of hepatitis C virus genome Biochem Biophys Res Commun 215 744 749 7488017 1:CAS:528:DyaK2MXos1Knt70%3D 10.1006/bbrc.1995.2526
133. P Simmonds 1999 Viral heterogeneity of the hepatitis C virus J Hepatol 31 54 60 10622561 10.1016/S0168-8278(99)80375-4 (Pubitemid 30002692)
134. P Simmonds J Bukh C Combet G Deléage N Enomoto S Feinstone P Halfon G Inchauspé C Kuiken G Maertens M Mizokami DG Murphy H Okamoto JM Pawlotsky F Penin E Sablon T Shin-I LJ Stuyver HJ Thiel S Viazov AJ Weiner A Widell 2005 Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 962 973 16149085 1:CAS:528: DC%2BD2MXhtFGlsbbI 10.1002/hep.20819 (Pubitemid 41401136)
135. M Mizokami T Gojobori K Ohba K Ikeo XM Ge T Ohno E Orito JY Lau 1996 Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes J Hepatol 24 622 624 8773919 1:STN:280:DyaK28zmvF2rsg%3D%3D 10.1016/S0168-8278(96) 80149-8 (Pubitemid 26167588)
136. E Schreier M Roggendorf G Driesel M Höhne S Viazov 1996 Genotypes of hepatitis C virus isolates from different parts of the world Arch Virol Suppl 11 185 193 8800799 1:STN:280:DyaK28znvFGntQ%3D%3D (Pubitemid 126446190)
137. Walsh N, Verstner A, Douple A, Vitoria M, Lo Y-R. The silent epidemic: responding to viral hepatitis among people who inject drugs. International Harm Reduction Association (IHRA). 2010:71-80. http://www.ihra.net/files/2010/06/15/ GlobalState2010-Section3-Web.pdf
138. H Hagan ER Pouget DC Des Jarlais C Lelutiu-Weinberger 2008 Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place Am J Epidemiol 168 1099 1109 18849303 10.1093/aje/kwn237
139. PK Nelson BM Mathers B Cowie H Hagan D Des Jarlais D Horyniak L Degenhardt 2011 Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews Lancet 378 571 583 21802134 10.1016/S0140-6736(11)61097-0
140. T Nakano L Lu P Liu OG Pybus 2004 Viral gene sequences reveal the variable history of hepatitis C virus infection among countries J Infect Dis 190 1098 1108 15319860 1:CAS:528:DC%2BD2cXosVWmsL8%3D 10.1086/422606 (Pubitemid 39186797)
141. MH Nguyen EB Keeffe 2004 Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9 Rev Gastroenterol Disord 4 S14 S21 15184820
142. L van Asten I Verhaest S Lamzira I Hernandez-Aguado R Zangerle F Boufassa G Rezza B Broers JR Robertson RP Brettle J McMenamin M Prins A Cochrane P Simmonds RA Coutinho S Bruisten European and Italian Seroconverter Studies 2004 Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis J Infect Dis 189 292 302 14722895 10.1086/380821 (Pubitemid 38147254)
143. OG Pybus MA Charleston S Gupta A Rambaut EC Holmes PH Harvey 2001 The epidemic behavior of the hepatitis C virus Science 292 2323 2325 11423661 1:CAS:528:DC%2BD3MXkslSht78%3D 10.1126/science.1058321 (Pubitemid 32568053)
144. OG Pybus A Cochrane EC Holmes P Simmonds 2005 The hepatitis C virus epidemic among injecting drug users Infect Genet Evol 5 131 139 15639745 10.1016/j.meegid.2004.08.001 (Pubitemid 40090232)
145. SM Kamal IA Nasser 2008 Hepatitis C genotype 4: what we know and what we don't yet know Hepatology 47 1371 1383 18240152 1:CAS:528:DC%2BD1cXkslOjsLg%3D 10.1002/hep.22127 (Pubitemid 351547923)
146. J Verbeeck P Maes P Lemey OG Pybus E Wollants E Song F Nevens J Fevery W Delport S Van der Merwe M Van Ranst 2006 Investigating the origin and spread of hepatitis C virus genotype 5a J Virol 80 4220 4226 16611881 1:CAS:528: DC%2BD28Xkt1Okurk%3D 10.1128/JVI.80.9.4220-4226.2006
147. C Henquell C Cartau AJ Abergel H Laurichesse C Regagnon C De Champs JL Bailly H Peigue-Lafeuille 2004 High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002 J Clin Microbiol 42 3030 3035 15243055 10.1128/JCM.42.7.3030-3035.2004 (Pubitemid 38938053)
148. CW Shepard L Finelli MJ Alter 2005 Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 588 567 10.1016/S1473-3099(05)70216-4 (Pubitemid 41196755)
149. A Neaigus M Zhao VA Gyarmathy L Cisek SR Friedman RC Baxter 2008 Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal J Urban Health 85 309 322 18340537 10.1007/s11524-008-9271-1
150. International Harm Reduction Association (IHRA) (2008) The Global State of Harm Reduction 2008: mapping the response to drug-related HIV and hepatitis C epidemics.
151. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010) Trends in injecting drug use in Europe.
152. KP Burke AL Cox 2010 Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence Immunol Res 47 216 227 20066508 1:CAS:528:DC%2BC3cXnvVenurg%3D 10.1007/s12026-009-8152-3
153. K Hiroishi T Ito M Imawari 2008 Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence J Gastroenterol Hepatol 23 1473 1482 18761560 1:CAS:528:DC%2BD1cXhtlOmu7rM 10.1111/j.1440-1746. 2008.05475.x
154. K Weigand W Stremmel J Encke 2007 Treatment of hepatitis C virus infection World J Gastroenterol 13 1897 1905 17461488 1:CAS:528: DC%2BD2sXmsFOnsLw%3D (Pubitemid 46758855)
155. T Wilkins JK Malcolm D Raina RR Schade 2010 Hepatitis C: diagnosis and treatment Am Fam Physician 81 1351 1357 20521755
156. J Golden RM Conroy AM O'Dwyer D Golden JB Hardouin 2006 Illness-related stigma, mood and adjustment to illness in persons with hepatitis C Soc Sci Med 63 3188 3198 17010490 10.1016/j.socscimed.2006.08.005 (Pubitemid 44648500)
157. GY Minuk A Gutkin SG Wong KD Kaita 2005 Patient concerns regarding chronic hepatitis C infections J Viral Hepat 12 51 57 15655048 1:STN:280:DC%2BD2M%2FivVKrtw%3D%3D 10.1111/j.1365-2893.2005.00553.x (Pubitemid 40188774)